Etaracizumab, CAS 892553-42-3

Product Description: Etaracizumab (LM 609) is an αvβ3 integrin IgG1 monoclonal antibody. Etaracizumab inhibits angiogenesis and melanoma tumor growth. Etaracizumab can be used to research anticancer[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Hersey P, et al. A randomized phase 2 study of etaracizumab, a monoclonal antibody against integrin alpha(v)beta(3), + or - dacarbazine in patients with stage IV metastatic melanoma. Cancer. 2010 Mar 15;116(6):1526-34.

CAS Number: 892553-42-3

Molecular Weight: 144.3 (kDa)

Compound Purity: 95.00

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: Integrin

• Artikelnummer: MEXHY-P99291-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99291-5
• Green Labware: Nein
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK